Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock
Clinical trial NCT07569536 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07569536
- Sponsor
- Hospices Civils de Lyon
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-10-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.